(Updated - May 7, 2026 7:56 AM EDT)

Guggenheim analyst Michael Schmidt raised the price target on BeOne Medicines ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE